Literature DB >> 26781765

Increased HDL Size and Enhanced Apo A-I Catabolic Rates Are Associated With Doxorubicin-Induced Proteinuria in New Zealand White Rabbits.

Victoria López-Olmos1, Elizabeth Carreón-Torres1,2, María Luna-Luna1, Cristobal Flores-Castillo1, Miriam Martínez-Ramírez1, Rocío Bautista-Pérez1,2, Martha Franco2,3, Julio Sandoval-Zárate2,4, Francisco-Javier Roldán5, Alberto Aranda-Fraustro6, Elizabeth Soria-Castro6, Mónica Muñoz-Vega1, José-Manuel Fragoso1,2, Gilberto Vargas-Alarcón1,2, Oscar Pérez-Méndez7,8.   

Abstract

The catabolism and structure of high-density lipoproteins (HDL) may be the determining factor of their atheroprotective properties. To better understand the role of the kidney in HDL catabolism, here we characterized HDL subclasses and the catabolic rates of apo A-I in a rabbit model of proteinuria. Proteinuria was induced by intravenous administration of doxorubicin in New Zealand white rabbits (n = 10). HDL size and HDL subclass lipids were assessed by electrophoresis of the isolated lipoproteins. The catabolic rate of HDL-apo A-I was evaluated by exogenous radiolabelling with iodine-131. Doxorubicin induced significant proteinuria after 4 weeks (4.47 ± 0.55 vs. 0.30 ± 0.02 g/L of protein in urine, P < 0.001) associated with increased uremia, creatininemia, and cardiotoxicity. Large HDL2b augmented significantly during proteinuria, whereas small HDL3b and HDL3c decreased compared to basal conditions. HDL2b, HDL2a, and HDL3a subclasses were enriched with triacylglycerols in proteinuric animals as determined by the triacylglycerol-to-phospholipid ratio; the cholesterol content in HDL subclasses remained unchanged. The fractional catabolic rate (FCR) of [(131)I]-apo A-I in the proteinuric rabbits was faster (FCR = 0.036 h(-1)) compared to control rabbits group (FCR = 0.026 h(-1), P < 0.05). Apo E increased and apo A-I decreased in HDL, whereas PON-1 activity increased in proteinuric rabbits. Proteinuria was associated with an increased number of large HDL2b particles and a decreased number of small HDL3b and 3c. Proteinuria was also connected to an alteration in HDL subclass lipids, apolipoprotein content of HDL, high paraoxonase-1 activity, and a rise in the fractional catabolic rate of the [(131)I]-apo A-I.

Entities:  

Keywords:  Atherosclerosis; Coronary heart disease; HDL; Lipoprotein metabolism; Paraoxonase-1; Renal failure

Mesh:

Substances:

Year:  2016        PMID: 26781765     DOI: 10.1007/s11745-016-4120-6

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  45 in total

1.  Clearance of postprandial and lipolytically modified human HDL in rabbits and rats.

Authors:  G F Lewis; B Lamarche; K D Uffelman; A C Heatherington; M A Honig; L W Szeto; P H Barrett
Journal:  J Lipid Res       Date:  1997-09       Impact factor: 5.922

2.  Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis.

Authors:  P T Williams; R M Krauss; A V Nichols; K M Vranizan; P D Wood
Journal:  J Lipid Res       Date:  1990-06       Impact factor: 5.922

Review 3.  Inflammation alters HDL composition and function: implications for HDL-raising therapies.

Authors:  Gunther Marsche; Marcus D Saemann; Akos Heinemann; Michael Holzer
Journal:  Pharmacol Ther       Date:  2012-12-14       Impact factor: 12.310

4.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

Authors:  G R Castro; C J Fielding
Journal:  Biochemistry       Date:  1988-01-12       Impact factor: 3.162

5.  Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndrome.

Authors:  Ken Aizawa; Satoshi Takeda; Yoshihito Tashiro; Keigo Yorozu; Michinori Hirata; Hirotaka Kanada; Yoshiyuki Moriguchi; Koichi Endo
Journal:  Am J Nephrol       Date:  2012-10-30       Impact factor: 3.754

6.  Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model.

Authors:  B Lamarche; K D Uffelman; G Steiner; P H Barrett; G F Lewis
Journal:  J Lipid Res       Date:  1998-06       Impact factor: 5.922

7.  Nuclear hormone receptors in podocytes.

Authors:  Simran Khurana; Leslie A Bruggeman; Hung-Ying Kao
Journal:  Cell Biosci       Date:  2012-09-20       Impact factor: 7.133

8.  Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.

Authors:  Liang He; Lili Hao; Xin Fu; Mingshu Huang; Rui Li
Journal:  BMC Nephrol       Date:  2015-04-11       Impact factor: 2.388

9.  Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.

Authors:  David J Kennedy; W H Wilson Tang; Yiying Fan; Yuping Wu; Shirley Mann; Michael Pepoy; Stanley L Hazen
Journal:  J Am Heart Assoc       Date:  2013-04-04       Impact factor: 5.501

10.  Effect of methanolic fraction of Kalanchoe crenata on metabolic parameters in adriamycin-induced renal impairment in rats.

Authors:  René Kamgang; Angèle F Foyet; Jean-Louis O Essame; Jeanne Y Ngogang
Journal:  Indian J Pharmacol       Date:  2012 Sep-Oct       Impact factor: 1.200

View more
  5 in total

1.  Hyperuricemia is Associated with Increased Apo AI Fractional Catabolic Rates and Dysfunctional HDL in New Zealand Rabbits.

Authors:  Miriam Martínez-Ramírez; Cristóbal Flores-Castillo; L Gabriela Sánchez-Lozada; Rocío Bautista-Pérez; Elizabeth Carreón-Torres; José Manuel Fragoso; José Manuel Rodriguez-Pérez; Fernando E García-Arroyo; Victoria López-Olmos; María Luna-Luna; Gilberto Vargas-Alarcón; Martha Franco; Oscar Pérez-Méndez
Journal:  Lipids       Date:  2017-09-22       Impact factor: 1.880

2.  High-density lipoprotein 3 cholesterol is a predictive factor for arterial stiffness: a community-based 4.8-year prospective study.

Authors:  Fan Wang; Xiaona Wang; Ping Ye; Ruihua Cao; Yun Zhang; Yue Qi; Dong Zhao
Journal:  Lipids Health Dis       Date:  2018-01-05       Impact factor: 3.876

3.  Lipoprotein modulation of proteinuric renal injury.

Authors:  Yohei Tsuchida; Jianyong Zhong; Tadashi Otsuka; Anna Dikalova; Ira Pastan; G M Anantharamaiah; MacRae F Linton; Patricia G Yancey; T Alp Ikizler; Agnes B Fogo; Haichun Yang; Valentina Kon
Journal:  Lab Invest       Date:  2019-04-24       Impact factor: 5.662

4.  Effect of renal function on high-density lipoprotein particles in patients with coronary heart disease.

Authors:  Long Jieni; Xue Yazhi; Zeng Xiaorong; Liu Dan; Ma Yusheng; Rao Jiahuan; Zhang Bin; Li Li; Guo Zhigang
Journal:  BMC Cardiovasc Disord       Date:  2021-11-12       Impact factor: 2.298

5.  Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab.

Authors:  Elizabeth W Thompson; Biniyam G Demissei; Amanda M Smith; Priya Brahmbhatt; Jessica Wang; Amy Clark; Angela DeMichele; Vivek Narayan; Payal Shah; Lova Sun; Benedicte Lefebvre; Michael G Fradley; Joseph R Carver; W H Wilson Tang; Bonnie Ky
Journal:  JACC Basic Transl Sci       Date:  2021-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.